COV2Base-A Rare Disease by COVID Study

Clinical trial NCT04564274 · COMPLETED

Trial details

NCT number: NCT04564274
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Status: COMPLETED
Study type: OBSERVATIONAL

Chronic Health Conditions Older Age is Associated With Increased Pathogenicity

Start date: 2020-10-04
Primary completion: 2022-05-20
Enrollment: 1748

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.